Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with significant revenue growth, improved gross margins, and a turnaround from a net loss to net income. Operating expenses increased due to strategic investments, indicating a focus on growth. Despite risks mentioned, the financial metrics and positive EBITDA growth suggest a favorable outlook. The absence of negative sentiment in the Q&A further supports a positive sentiment, likely leading to a stock price increase of 2% to 8% over the next two weeks.
Revenue Revenue for Q1 2026 was $68.5 million, representing a 12% increase year-over-year. This growth was driven by strong demand for our Flexitouch and Entre systems, as well as increased adoption of our products in the home care setting.
Gross Margin Gross margin for the quarter was 72.3%, up from 70.8% in Q1 2025. The improvement was primarily due to favorable product mix and operational efficiencies.
Net Income Net income for Q1 2026 was $4.2 million, compared to a net loss of $1.5 million in Q1 2025. This turnaround was attributed to higher revenue and improved gross margins.
Operating Expenses Operating expenses were $42.7 million, up 8% year-over-year. The increase was mainly due to higher investments in sales and marketing initiatives.
Adjusted EBITDA Adjusted EBITDA for Q1 2026 was $12.3 million, a 25% increase from $9.8 million in Q1 2025. This growth was driven by higher revenue and improved operational efficiencies.
The selected topic was not discussed during the call.
Forward-looking statements: The company's forward-looking statements are based on current expectations and involve inherent risks and uncertainties that could cause actual results to differ materially. These risks are identified in the Risk Factors section of the company's annual report on Form 10-K and the most recent 10-Q filing.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The earnings call reveals strong financial performance with significant revenue growth, improved gross margins, and a turnaround from a net loss to net income. Operating expenses increased due to strategic investments, indicating a focus on growth. Despite risks mentioned, the financial metrics and positive EBITDA growth suggest a favorable outlook. The absence of negative sentiment in the Q&A further supports a positive sentiment, likely leading to a stock price increase of 2% to 8% over the next two weeks.
The company's strong Q4 financial performance, including a 21% revenue increase and improved margins, reflects positive momentum. Raised revenue guidance and successful product growth in airway clearance further bolster sentiment. While there are concerns regarding Medicare prior authorization, the company's strategic investments and partnerships mitigate risks. The Q&A section reveals cautious optimism and readiness to address challenges, supporting a positive outlook. Overall, the combination of strong financials and strategic growth initiatives suggests a likely positive stock price movement in the near term.
The earnings call shows strong financial performance with significant revenue and income growth. The company has strategic partnerships, increased market awareness, and operational efficiencies driving growth. Despite a decrease in cash due to loan repayment, the underlying cash position improved. The Q&A highlighted strong market strategies and growth drivers, although some specifics were avoided. Overall, the positive financial metrics and strategic initiatives suggest a likely positive stock movement over the next two weeks.
The earnings call reflects a mixed sentiment. The company shows positive signs with strong product launches (Nimbl, AffloVest) and strategic initiatives (CRM, AI tools), but faces challenges such as increased operating expenses and commercial channel weakness. Despite exceeding Q2 expectations, guidance was only slightly raised, indicating cautious optimism. The Q&A reveals uncertainties in policy updates and market share data. The stock buyback and cash position are positives, but the overall sentiment remains balanced, leading to a neutral prediction for stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.